Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion

Yoshifumi Iwamaru1, Takato Takenouchi, Kazumasa Ogihara

  • 1Research Center for Prion Diseases, National Institute of Animal Health, Kannondai 3-1-5, Tsukuba, Ibaraki 305-8602, Japan.

Journal of Virology
|November 24, 2006
PubMed

Insights

A new microglial cell line (MG20) was developed from prion protein-overexpressing mice. This cell line supports prion replication and infection, offering a valuable model for studying prion diseases.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Cell Biology

Background:

  • Microglia are implicated in the pathogenesis of prion diseases.
  • Existing models may not fully capture microglial roles in prion propagation.

Purpose of the Study:

  • To establish a novel microglial cell line for prion disease research.
  • To characterize the susceptibility of this cell line to various prion strains.

Main Methods:

  • Generation of a microglial cell line (MG20) from neonatal tga20 mice overexpressing prion protein.
  • Infection of MG20 cells with Chandler scrapie, ME7, Obihiro scrapie, and bovine spongiform encephalopathy agents.
  • Monitoring prion protein replication and accumulation in infected cells.

Main Results:

  • MG20 cells showed sustained replication and accumulation of disease-associated prion protein up to the 15th passage after Chandler scrapie exposure.
  • MG20 cells were susceptible to ME7, Obihiro scrapie, and bovine spongiform encephalopathy agents.
  • Demonstrated persistent infection of MG20 cells with different prion strains.

Conclusions:

  • The novel MG20 microglial cell line is a robust in vitro model for prion diseases.
  • This model facilitates the study of microglial involvement in prion pathogenesis.
  • MG20 cells support persistent infection with diverse prion strains, aiding research into disease mechanisms.

Related Concept Videos